September 2, 2025 - 09:38

Jake Sullivan, a former National Security Advisor, has shed light on what he describes as a significant yet under-reported aspect of Donald Trump’s foreign policy. Sullivan claims that during Trump's presidency, the former leader prioritized strengthening relations with Pakistan at the expense of the United States' longstanding partnership with India.
This shift in focus, according to Sullivan, was influenced by Trump's familial business interests, suggesting that personal financial motivations may have played a role in shaping U.S. foreign relations. Sullivan's remarks highlight concerns over the potential implications of such decisions on international diplomacy and regional stability.
The critique points to a broader narrative about how personal interests can intertwine with national policy, raising questions about the integrity and motivations behind foreign relations. As the geopolitical landscape continues to evolve, the ramifications of these choices remain a topic of discussion among analysts and policymakers alike, reflecting on the future of U.S. engagements in South Asia.
July 18, 2026 - 03:09
Huntington University Hires Dr. Aaron Wilkinson as Chair of Department of Business and EconomicsHuntington University has appointed Dr. Aaron Wilkinson as the new chair of its Department of Business and Economics. The private Christian liberal arts institution, located in Indiana, made the...
July 17, 2026 - 04:40
Arvest to open first Texas locationFayetteville-based Arvest Bank is set to open its first location in Texas later this year. The new office, a loan production facility, will be situated in Frisco, a fast-growing suburb north of...
July 16, 2026 - 12:32
Capital One (COF) Unveils Up To $500 In Spark Business Travel CreditsCapital One Financial (NYSE:COF) has launched a new perk for its Spark Cash Plus and Spark Cash business cardholders, offering up to $500 in travel credits. The credits are tied directly to...
July 15, 2026 - 22:57
Eli Lilly is reinventing the pharma businessThe world`s largest drugmaker is quietly reshaping its business model, moving beyond the traditional focus on treating illness and into the realm of prevention. Eli Lilly, known for blockbuster...